期刊文献+

胰腺癌外科治疗现状:争议与共识 被引量:4

Current surgical management of pancreatic cancer: controversies and consensus
原文传递
导出
摘要 现阶段胰腺癌的外科治疗,虽有共识但更有争议,也存在一些正在探索中的问题。手术技术的进步、新的有效药物的出现、更为严谨的临床研究的开展、治疗模式的优化以及观念的更新,是促成胰腺癌外科治疗取得突破性进展的重要因素。 There currently exist more controversies than consensus in the field of surgical management of pancreatic cancer, in addition to many problems still in exploration. The advances of surgical technique, application of novel therapeutic agents, conduct of more strict and scientific clinical trials, optimization of management model and update of perceptions will all contribute to the dramatic breakthroughs in this field.
作者 郝纯毅
出处 《中国实用外科杂志》 CSCD 北大核心 2011年第9期773-777,共5页 Chinese Journal of Practical Surgery
关键词 胰腺癌 外科治疗 辅助治疗 新辅助治疗 治疗模式 pancreatic cancer surgical management adjuvant therapy neoadjuvant therapy management model
  • 相关文献

参考文献23

  • 1Neoptolemos J P,Stoeken DD, Friess H, el al. A randomized trial of chemoradiotherapy and chemotherapy after reseclion of panereatie eancer [J ]. N Engl J Med,2004,350( 12): 1200-1210.
  • 2Oettle H, Post S, Neuhaus P, et al. Adjuvanl chemotherapy with gemcitabine vs observation in patients undergoing cnralive-intent resection of pancreatic cancer: a randomized controlled trial [ J ]. J AM A, 2007,297(3):267-277.
  • 3Karanieolas PJ, Davies E, Kunz R, et al. The pylorus: lake it or leave it? Systematic review and mela-analysis of pylorus-preserving versus standard Whipple panereaticoduodeneetotiay for panereatie or periampullary eaneer [J]. Ann Surg Oneol, 2007, 14(6):1825-1834.
  • 4Diener MK, Knaebel HP, Heukaufer C, et al. A syslemalic review and melaanalysis of pylorus-preserving versus elassical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma [J]. Ann Surg, 2007, 245(2): 187-200.
  • 5Verbeke CS, Leitch D, Menon KV, et al. Redefining the R1 resection in pancreatic cancer [J]. Br J Surg, 2006, 93(10): 1232-1237.
  • 6Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are RI resections [J]. Ann Surg Oncol,2008,15(6): 1651-1660.
  • 7Jamieson NB, Foulis AK, Oien KA, et al. Positive mobilization margins alone do not influence survival following pancreatic ductal adenoca rcinoma [ J ]. Ann Surg, 2010,251 (6) : 1003 - 1010.
  • 8Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular reseclion: margin status and survival duration [J]. J Gaslrointest Surg,2004,8(8):935-949.
  • 9Riediger H, Makowiec F, Fischer E, et al. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection [J]. J Gastroinles! Surg, 2006,10(8):1106-1115.
  • 10Zhang J, Qian HG, Leng JH, et al. Long mesentericoportal vein resection and end-to-end anastomosis wilhout graft in pancreaticoduodenectomy [J]. J Gastrointest Surg, 2009,13(8): 1524-1528.

二级参考文献14

  • 1腹腔镜结肠直肠癌根治手术操作指南(2006版)[J].外科理论与实践,2006,11(5):462-464. 被引量:275
  • 2The Japanese Gastric Cancer Association. Guidelines for thetreatment of gastric cancer. Tokyo: Kanehara, 2004.
  • 3Rodriguez E, Chitwood WR. Robotics in cardiac surgery [J].Seand J Surg, 2009, 98(2): 120-124.
  • 4Gao C. Yang M, Wu Y, et al. Hybrid coronary revascularization by endoscopic robotic coronary artery bypass grafting on beating heart and stent placement [J]. Ann Thorac Surg, 2009, 87(3): 737-741.
  • 5Sharma NL, Shah NC, Neal DE. Robotic-assisted laparoscopic prostatectomy [ J ]. Br J Cancer, 2009, 101 (9): 1491-1496.
  • 6Chen CC, Falcone T. Robotic gynecologic surgery: past, present, and future[J]. Clin Obstet Gynecol, 2009, 52(3):335-343.
  • 7Louis G, Hubert J, Ladriere M, et al. Robotic-assisted laparoscopic donor nephrectomy for kidney transplantation. An evaluation of 35 procedures [J ]. Nephrol Ther, 2009, 5(7):623-630.
  • 8Song J, Oh SJ, Kang WH, et al. Robot-assisted gastrectomy with lymph node dissection for ga.stric cancer: lessons learned from an initial 100 consecutive procedures [J]. Ann Surg, 2009, 249(6): 927-932.
  • 9Baik SH, Lee WJ, Rha KH,et al. Robotic total mesorectal excision for rectal cancer using four robotic arms [J]. Surg Endosc, 2008,22(3):792-797.
  • 10Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital [J]. Arch Surg, 2003, 138(7):777-784.

共引文献54

同被引文献35

  • 1倪泉兴,傅德良,蒋永剑,张群华,姚琪远,虞先浚,张延龄.胰头癌淋巴转移特点的探索和影响的因素[J].中华肝胆外科杂志,2004,10(4):231-234. 被引量:20
  • 2Egawa S, Takeda K, Fukuyama S, et al. Clinicopathological as- pects of small pancreatic cancer. Pancreas,2004,28(3 ) :235-240.
  • 3Kayahara M, Funaki K, Tajima H, et al. Surgical implication of micrometastasis for pancreatic cancer. Pancreas, 2010,39 ( 6 ) : 884-888.
  • 4Kurahara H, Takao S, Maemura K, et al. Impact of lymph node micrometastasis in patients with pancreatic head cancer. World J Surg,2007,31 (3) :483-492.
  • 5Balie M, Williams A, Dandachi N, et al. Micrometastasis: detec- tion methods and clinical importance. Cancer Biomark,2011,9( 1- 6) :397-419.
  • 6Lee SE, Jang JY, Kim MA, et al. Clinical implications of inmm- nohistochemically demonstrated lymph node micrometastasis in re- sectable pancreatic cancer. J Korean Med Sci,2011,26 (7) : 881 - 885.
  • 7Kat'uchov:i J, Bober J, Kat'uch V, et al. Significance of lymph node micrometastasis in pancreatic cancer patients. Eur Surg Res, 2012,48(1) :10-15.
  • 8Derneure M J, Doffek KM, Komorowski RA, et al. Adenocat:inn- ma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer, 1998,83(7) :1328-1334.
  • 9Tanaka S, Pero SC, Taguchi K, et al. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst,2006,98 (7) :491-498.
  • 10Ochi N, Matsuo Y, Sawai H, et al. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangio- genesis. Pancreas ,2007,34 ( 4 ) :444-451.

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部